TITLE

Metabolic Syndrome in HIV-Infected Patients from an Urban, Midwestern US Outpatient Population

AUTHOR(S)
Mondy, Kristin; Overton, Edgar Turner; Grubb, Jessica; Shao Tong; Seyfried, Warren; Powderly, William; Yarasheski, Kevin
PUB. DATE
March 2007
SOURCE
Clinical Infectious Diseases;3/1/2007, Vol. 44 Issue 5, p726
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. The association between the use of highly active antiretroviral therapy (HAART) and an increased risk of metabolic syndrome and cardiovascular disease remains unclear. Methods. We conducted a prospective, cross-sectional study of the risk factors associated with metabolic syndrome and cardiovascular disease among patients from an urban outpatient human immunodeficiency virus (HIV) clinic. Evaluation included laboratory data that were obtained after an overnight fast and a health survey that assessed traditional risk factors associated with cardiovascular disease, HIV-related factors, and comorbidities. Data collected were compared with data files from a cohort from the National Health and Nutrition Examination Survey (NHANES; 2001-2002) of persons who were seronegative for HIV infection who were matched for age, sex, race, and tobacco use. Results. Four hundred seventy-one HIV-infected subjects provided complete data. The overall prevalence of metabolic syndrome was similar between the group HIV-infected patients and the group of persons who were seronegative for HIV infection (25.5% vs. 26.5%, respectively), although the HIV-infected patients had a significantly smaller waist circumference, lower body mass index, lower high-density lipoprotein cholesterol levels, higher triglyceride levels, and lower glucose levels, compared with the subjects from the NHANES cohort. Framingham 10-year risk scores were also similar between the 2 groups. HIV-infected patients with metabolic syndrome were more likely to be diabetic, older, and white and have a high CD4 cell count and body mass index, compared with patients without metabolic syndrome (P < .05 for all). The type or duration of antiretroviral therapy was not an independent risk factor for metabolic syndrome. Conclusions. The prevalence of metabolic syndrome is high among HIV-infected persons, but not higher than the prevalence among HIV-uninfected persons. Traditional risk factors play a more significant role in the development of metabolic syndrome than do HIV treatment-associated factors.
ACCESSION #
24623962

 

Related Articles

  • Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans. Womack, Julie A.; Goulet, Joseph L.; Gibert, Cynthia; Brandt, Cynthia; Chang, Chung Chou; Gulanski, Barbara; Fraenkel, Liana; Mattocks, Kristin; Rimland, David; Rodriguez-Barradas, Maria C.; Tate, Janet; Yin, Michael T.; Justice, Amy C. // PLoS ONE;2011, Vol. 6 Issue 2, p1 

    Background: HIV infection has been associated with an increased risk of fragility fracture. We explored whether or not this increased risk persisted in HIV infected and uninfected men when controlling for traditional fragility fracture risk factors. Methodology/Principal Findings: Cox regression...

  • Changes in the Incidence and Predictors of Wasting Syndrome Related to Human Immunodeficiency Virus Infection, 1987–1999. Smit, Ellen; Skolasky, Richard L.; Dobs, Adrian S.; Calhoun, Bridget C.; Visscher, Barbara R.; Palella, Frank J.; Jacobson, Lisa P. // American Journal of Epidemiology;Aug2002, Vol. 156 Issue 3, p211 

    The authors examined the impact of potent antiretroviral therapy (ART) on the diagnosis of wasting syndrome in the Multicenter AIDS Cohort Study. Study time was divided into the periods 1988–1990, 1991–1993, 1994–1995, and 1996–1999 to correspond to different...

  • Malnutrition in hospitalized people living with HIV/AIDS: evidence from a cross-sectional study from Chengdu, China. Wen Hu; Hua Jiang; Wei Chen; Sheng-Hua He; Bin Deng; Wen-Yuan Wang; Yan Wang; Charles Damien Lu; Karen Klassen; Jun Zeng // Asia Pacific Journal of Clinical Nutrition;Dec2011, Vol. 20 Issue 4, p544 

    Objectives: Nutrition support has long been ignored in China's HIV/AIDS treatment and care. The objectives of this project were to evaluate the prevalence of malnutrition among Chengdu urban HIV positive patients, and to provide evidence for further nutritional intervention. Materials and...

  • Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria. Agaba, P. A.; Sule, H. M.; Ojoh, R. O.; Hassan, Z.; Apena, L.; Mu'azu, M. A.; Badung, B.; Agbaji, O. O.; Idoko, J. A.; Kanki, P. // International Journal of STD & AIDS;Jun2009, Vol. 20 Issue 6, p410 

    AIDS-related Kaposi's sarcoma (AIDS-KS) remains a significant cause of morbidity and mortality. We describe the pattern of presentation and survival in Jos, Nigeria. We identified 48 HIV-positive patients with AIDS-KS and matched them for age and sex with an equal number of HIV-positive patients...

  • Body Mass Index and CD4+ T-Lymphocyte Recovery in HIV-Infected Men with Viral Suppression on Antiretroviral Therapy. Palermo, Brandon; Bosch, Ronald J.; Bennett, Kara; Jacobson, Jeffrey M. // HIV Clinical Trials;Jul/Aug2011, Vol. 12 Issue 4, p222 

    Purpose: To better characterize the relationship between body mass index (BMI) and CD4+ T-lymphocyte recovery in HIV disease.Methods: We analyzed the association between baseline BMI and CD4+ T-lymphocyte increases, as well as the association between BMI and immune activation (CD38 and HLA-DR...

  • Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals. Worm, Signe W.; Sabin, Caroline A.; Reiss, Peter; El-Sadr, Wafaa; Monforte, Antonella D'Arminio; Pradier, Christian; Thiebaut, Rodolphe; Law, Matthew; Rickenbach, Martin; De Wit, Stephane; Lundgren, Jens D.; Friis-Møller, Nina // Diabetes Care;Mar2009, Vol. 32 Issue 3, p474 

    OBJECTIVE -- It is much debated whether the metabolic syndrome contributes additional information over and above that provided by the individual components of the syndrome alone. Among HIV-infected individuals, we investigated whether any particular combinations of the components included in the...

  • Improved Lipid Profiles and Maintenance of Virologic Control in Heavily Pretreated HIV-Infected Patients Who Switched from Stavudine to Tenofovir Treatment. Schewe, Carl Knud; Maserati, Renato; Wassmer, Gernot; Adam, Axel; Weitner, Lutwin // Clinical Infectious Diseases;1/1/2006, Vol. 42 Issue 1, p145 

    A retrospective chart analysis of 66 human immunodeficiency virus type 1 (HIV-1)-infected patients whose treatment was switched from stavudine to tenofovir without any other treatment changes was conducted. The mean total cholesterol values decreased significantly within 3 months after the...

  • Association of BMI Category Change with TB Treatment Mortality in HIV-Positive Smear-Negative and Extrapulmonary TB Patients in Myanmar and Zimbabwe. Benova, Lenka; Fielding, Katherine; Greig, Jane; Nyang'wa, Bern-Thomas; Casas, Esther Carrillo; Fonseca, Marcio Silveira da; Cros, Philipp du // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Objective: The HIV epidemic has increased the proportion of patients with smear-negative and extrapulmonary tuberculosis (TB) diagnoses, with related higher rates of poor TB treatment outcomes. Unlike in smear-positive pulmonary TB, no interim markers of TB treatment progress are systematically...

  • Obesity may have negative effect on CD4 counts in patients with HIV. Lewis, Jay; Volansky, Rob; Zacharyczuk, Colleen // Infectious Disease News;Nov2009, Vol. 22 Issue 11, p34 

    This article discusses a study which examined changes in body mass index and CD4 cell counts in obese patients with human immunodeficiency virus.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics